Atezolizumab in Combination With Bevacizumab and Chemotherapy Versus Bevacizumab and Chemotherapy in Recurrent Ovarian Cancer - a Randomized Phase III Trial
Phase of Trial: Phase III
Latest Information Update: 21 Dec 2018
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab (Primary) ; Doxorubicin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 12 Sep 2018 Status changed from not yet recruiting to recruiting.
- 12 Jun 2018 Planned initiation date changed from 1 Jul 2018 to 1 Aug 2018.
- 09 May 2018 Planned number of patients changed from 777 to 664.